DR. KAZUKI
YASUDA (Orcid ID : 0000-0002-6966-496X)
Accepted Article
Article type
: Editorial
Editorial
Bariatric and metabolic surgery in Asia: where are we, and where are we going?
Kazuki Yasuda✳︎1 1
Department of Metabolic Disorder, Diabetes Research Center, National Center for Global Health
and Medicine, JAPAN
✳︎Corresponding Kazuki Yasuda, Director, Department of Metabolic Disorder, Diabetes Research Center, National Center for Global Health and Medicine 1-8-1, Toyama Shinjuku-ku, Tokyo 162-8655, JAPAN Tel: +81-3-3202-7181 Fax: +81-3-3202-7364 Email:
[email protected]
Running title: Metabolic surgery in Asia
This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi: 10.1111/jdi.12893 This article is protected by copyright. All rights reserved.
The worldwide prevalence of obesity keeps growing, especially in Asian and African countries, but
Accepted Article
pharmacological treatment of obesity remains a huge challenge. Surgical intervention, known as bariatric surgery, achieves dramatic and sustained body weight loss in morbidly obese subjects; concomitantly, it results in substantial improvement of obesity-related comorbidities, especially diabetes mellitus, as many diabetic patients can reach “complete remission” (HbA1c 37.5 kg/m2, rather than > 40 kg/m2, and should be considered as a candidate therapy for Asians with 32.5 < BMI < 37.5 kg/m2, or even those with 27.5
